Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Type II Diabetes I: Introduction

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

Type II Diabetes II: Pathophysiology

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

Type I Diabetes II: Pathophysiology

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...

Diabetes Mellitus: Overview and Type I Subtype

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The association between carotid disease, arterial stiffness and diabetic retinopathy in type 2 diabetes: the Fremantle Diabetes Study Phase II.

Diabetic medicine : a journal of the British Diabetic Association·2020

Same author

Risk factors and outcomes of anxiety symptom trajectories in type 2 diabetes: the Fremantle Diabetes Study Phase II.

Diabetic medicine : a journal of the British Diabetic Association·2020

Same author

Clinical risk factors for depressive syndrome in Type 2 diabetes: the Fremantle Diabetes Study.

Diabetic medicine : a journal of the British Diabetic Association·2018

Same author

Feasibility of a multi-modal exercise program on cognition in older adults with Type 2 diabetes - a pilot randomised controlled trial.

BMC geriatrics·2017

Same author

Depression symptoms are persistent in Type 2 diabetes: risk factors and outcomes of 5-year depression trajectories using latent class growth analysis.

Diabetic medicine : a journal of the British Diabetic Association·2017

Same author

A population-based study of the association between dysglycaemia and hearing loss in middle age.

Diabetic medicine : a journal of the British Diabetic Association·2017

Search research articles

Related Experiment Videos

Ethnic diversity in type 2 diabetes.

¹University of Western Australia, School of Medicine and Pharmacology, Fremantle Hospital, Fremantle, Australia. tdavis@cyllene.uwa.edu.au

Diabetic Medicine : a Journal of the British Diabetic Association

|September 9, 2008

Summary

Ethnic differences in diabetes persist. Afro-Caribbeans (AC) had lower heart attack risk, while Indian-Asians (IA) faced higher kidney disease risk compared to White Caucasians (WC).

Area of Science:

Endocrinology
Public Health
Epidemiology

Background:

The UK Prospective Diabetes Study (UKPDS) cohort includes White Caucasians (WC), Indian-Asians (IA), and Afro-Caribbeans (AC).
Understanding ethnic variations in diabetes is crucial for targeted interventions.

Purpose of the Study:

To analyze ethnic differences in diabetes characteristics and vascular risk factors within the UKPDS cohort.
To investigate ethnic disparities in myocardial infarction and nephropathy risks.

Main Methods:

Review of published UKPDS data focusing on WC, IA, and AC participants.
Analysis of baseline characteristics, vascular risk factors, and long-term outcomes including myocardial infarction and renal complications.

Main Results:

Related Experiment Videos

Indian-Asians (IA) were younger with higher waist-hip ratio and sedentary lifestyles but lower hypertension and smoking rates.
Afro-Caribbeans (AC) exhibited poorer glycemic control but a favorable lipid profile.
AC patients had a 70% lower risk of myocardial infarction; IA ethnicity was linked to increased risk of albuminuria and renal failure.

Conclusions:

Sustained ethnic differences exist in diabetes presentation and vascular risk factors.
AC patients showed a significantly reduced myocardial infarction risk, independent of lipid profiles.
IA patients demonstrated a higher risk for nephropathy, warranting further investigation into macrovascular risks.